Anebulo Pharmaceuticals, Inc.
(NASDAQ: ANEB)
Anebulo Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in the provision of pharmaceutical services. Its product candidate, Selonabant, is a small molecule antagonist of cannabinoid binding receptor type-1. The company was founded by Joseph F. Lawler on April 23, 2020 and is headquartered in Lakeway, TX.
0.870 -
+0.015
(+1.75%)
Range
0.838 - 0.870
(3.82%)
Open
0.855
Previous Close
0.855
Bid Price
0.850
Bid Volume
11,300
Ask Price
0.865
Ask Volume
101
Volume
5,032
Value
3,419
Remark
-
Delayed prices. Updated at 30 Jan 2026 04:45.
Data powered by
View All Events
Loading Chart...
Please login to view stock data and analysis
